Max Robotics — Global Service Robot Directory + US Certification

About

Frank Verhaegen is a leading figure in the advancement of preclinical and translational radiation oncology, with his work fundamentally shaping how targeted radiation is delivered and verified. His primary research areas encompass small animal image-guided radiotherapy, Monte Carlo dosimetry, and novel in vivo treatment verification for brachytherapy. Verhaegen’s most significant contribution is the development of the Small Animal Radiation Research Platform (SARRP), a high-resolution system that delivers focal, kilo-voltage radiation under robotic control using cone-beam CT guidance. His seminal 2008 paper on this platform has garnered over 360 citations, establishing it as a foundational tool for preclinical research worldwide. He further solidified this contribution with a comprehensive system for dosimetric commissioning and Monte Carlo validation of the SARRP. Beyond preclinical work, Verhaegen has pioneered real-time in vivo dosimetry for High Dose Rate (HDR) brachytherapy using electronic portal imaging devices (EPIDs), addressing a critical gap in commercial treatment verification. His innovative approaches to automatic ultrasound probe positioning for image-guided radiotherapy also demonstrate his commitment to improving precision and reducing operator dependency in clinical workflows. Through these achievements, Verhaegen has bridged the gap between physics and biology, enabling more accurate and translatable cancer research.